Is QUCY or RANI more undervalued in 2026?

CirclFi compares Quantum Cyber N.V. (QUCY) and Rani Therapeutics Holdings, Inc (RANI) using 13 institutional-grade valuation models. QUCY has a Quality of Company score of 1.9/10 while RANI scores 6.0/10.

Which is a better buy — QUCY or RANI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do QUCY and RANI valuations compare?

QUCY at $2.56 and RANI at $0.95 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

QUCY vs RANI Valuation Comparison 2026 — Intrinsic Value Analysis

QUCY

Pharmaceutical Preparations

Quantum Cyber N.V.

Quality

1.9

out of 10

Value Trap

—

Price

$2.56

Last close

Models

10/13

Active

RANI

Pharmaceutical Preparations

Rani Therapeutics Holdings, Inc

Quality

6.0

out of 10

Value Trap

SAFE

Price

$0.95

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	QUCY Fair Value	QUCY Upside	RANI Fair Value	RANI Upside
Bayesian DCF	Intrinsic	$1.07	-58.3%	$0.22	-76.6%
Earnings Power Value	Intrinsic	$0.72	+75.8%	—	—
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.03	-98.7%	$0.37	-60.8%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for QUCY vs RANI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

QUCY vs RANI — Which Stock Is More Undervalued?

RANI scores higher with a 6.0/10 quality rating vs QUCY's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Quantum Cyber N.V. (QUCY) and Rani Therapeutics Holdings, Inc (RANI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

QUCY currently trades at $2.56 with a QOC of 1.9/10, while RANI trades at $0.95 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).